CDLXCDLXCommunication Services · Advertising Agencies

CDLX Stock Forecast: Cardlytics, Inc. Price Predictions for 2026-2027

Last close, 21 Aug 2026
$4.30
0.00% on the day

The 4 Wall Street analysts covering Cardlytics, Inc. hold a median 12-month price target of $5 — +16.3% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 83 of 100 as at 22 Aug 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$25.3M
Ticker Nerd rank
83 / 100
Median analyst target
$5.00
Analysts covering
4
Total return, dividends reinvested
1W
+1.7%
1M
+8.6%
YTD
−62.6%
1Y
−57.4%
From 52W high
−84.8%
From 52W low
+22.2%
$4
$28
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

CDLX stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Cardlytics, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 22 Aug 2026
83 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Accruals
99
Size
87
Growth
75
Issuance
72
Revisions
69
Quality
67
Value
61
Volatility
19
Momentum
6

Accruals (99): Reported profit is backed by cash, and the company is not expanding recklessly.

Momentum (6): The shares have been drifting down relative to others.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

CDLX stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on CDLX, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$5$10$15$20$25$30Oct 25Jan 26Apr 26Jul 26CDLXHigh $10.00Median $5.00Low $4.00

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says4 analysts
0 Buy3 Hold1 Sell
Low $4.00Median $5.00High $10.00

The green dot is the last close — the median target sits +16.3% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
8 Aug 2025Evercore ISI GroupMaintainsIn-Line$3.00$2.00
8 May 2025Lake StreetMaintainsHold
13 Mar 2025Evercore ISI GroupMaintainsIn-Line
13 Mar 2025Lake StreetMaintainsHold
13 Mar 2025NeedhamReiteratesHold
17 Jan 2025NeedhamReiteratesHold
7 Nov 2024NeedhamReiteratesHold
11 Oct 2024Evercore ISI GroupInitiatesIn-Line
16 Aug 2024Northland Capital MarketsDowngradeMarket Perform
15 Aug 2024B of A SecuritiesDowngradeUnderperform
8 Aug 2024Lake StreetDowngradeHold
8 Aug 2024NeedhamDowngradeHold
8 Aug 2024Northland Capital MarketsMaintainsOutperform
20 June 2024B of A SecuritiesReinstatesNeutral$11
18 June 2024Northland Capital MarketsInitiatesOutperform
11 June 2024NeedhamReiteratesBuy
9 May 2024Craig-HallumMaintainsBuy
9 May 2024NeedhamMaintainsBuy
9 Apr 2024NeedhamMaintainsBuy
15 Mar 2024Craig-HallumUpgradeBuy

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. CDLX appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

CDLX analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
Analysts raising
0
Analysts cutting
0
Fundamentals

Cardlytics, Inc. (CDLX) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
−0.2×

Cheaper than 78% of US stocks

Price / sales
0.1×

Cheaper than 95% of US stocks

Price / book
−1.6×

Cheaper than 95% of US stocks

EV / EBITDA
−13.4×

Cheaper than 86% of US stocks

Growth & margins
Revenue growth (YoY)
−36.5%

Higher than 7% of US stocks

Earnings growth (YoY)
Gross margin
50.5%

Higher than 63% of US stocks

Operating margin
−14.8%

Higher than 23% of US stocks

Net margin
−52.8%

Higher than 10% of US stocks

Returns & dividend
Return on equity
−513.2%

Higher than 3% of US stocks

Return on assets
−7.4%

Higher than 29% of US stocks

Dividend yield

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

CDLX vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelAdvertising Agencies
CompanyMarket capTKN rank
CDLXCardlytics, Inc.$25.3M
83
WIMIWiMi Hologram Cloud, Inc.$25.4M
11
MFMindForge, Inc.$32.8M
13
ACCSACCESS Newswire, Inc.$19.0M
88
SWAGStran & Co., Inc.$33.8M
72
DLPNDolphin Entertainment, Inc.$13.7M
77
TJGCTJGC Group Ltd.$47.1M
14

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Cardlytics, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest CDLX news & analysis

Cardlytics, Inc. (CDLX) Q2 2026 Earnings Call Transcript

Seeking Alpha · 6 Aug 2026neutral

Seeking Alpha published the transcript of Cardlytics, Inc.'s Q2 2026 earnings call, in which company management presented the quarter's results and answered analyst questions.

Why it matters — The transcript gives CDLX watchers a complete record of management's commentary on the company's second-quarter performance beyond what appears in the earnings release.

Cardlytics Second Quarter 2026 Financial Results Driven By Strong Operational Performance

Business Wire · 5 Aug 2026positive

Cardlytics announced its financial results for the second quarter ended June 30, 2026. CEO Amit Gupta reported the company came in within guidance across all key metrics, with margins improving every month of the quarter, and noted new advertiser relationships and deeper partnerships with existing financial institutions.

Why it matters — The quarter indicates Cardlytics' execution is translating into results, with in-guidance performance across key metrics and steadily improving monthly margins.

Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business Wire · 3 Aug 2026neutral

Cardlytics granted an aggregate of 50,000 restricted stock units to its newly appointed Chief Legal Officer, Chris Cheng, on Aug. 3, 2026. The RSUs were issued as material inducements to employment under Nasdaq Listing Rule 5635(c)(4) and the Cardlytics, Inc. 2022 Inducement Plan.

Why it matters — CDLX watchers would take note of the equity grant tied to the appointment of a new chief legal officer, marking a leadership change and a standard inducement-based compensation event.

Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business Wire · 31 July 2026neutral

Cardlytics granted 10,320 restricted stock units to 10 newly hired employees as inducements to join the company, approved by the Compensation Committee on July 29, 2026, under the 2022 Inducement Plan in accordance with Nasdaq Listing Rule 5635(c)(4).

Why it matters — The inducement grants signal that Cardlytics is adding new talent, which may support the company's operational and strategic initiatives going forward.

Cardlytics Appoints Chris Cheng as Chief Legal Officer

Business Wire · 29 July 2026neutral

Cardlytics has appointed Chris Cheng as Chief Legal Officer, effective August 3, 2026. Cheng will oversee the company's Legal and Compliance organization and serve on the Leadership Team.

Why it matters — A new chief legal officer with public-company and transformation experience could influence how Cardlytics navigates regulatory and compliance matters during its next phase of growth.

FAQ

Frequently asked questions about CDLX stock

What is the CDLX stock price forecast for 2026-2027?

The 4 Wall Street analysts covering Cardlytics, Inc. have a median 12-month price target of $5, with estimates ranging from $4 to $10. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is CDLX stock a buy right now?

Of the 4 analysts covering Cardlytics, Inc., 0 rate it a Buy, 3 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Cardlytics, Inc. 83 out of 100 across roughly 4,600 US stocks as at 22 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank CDLX?

As at 22 Aug 2026, Cardlytics, Inc. ranks 83 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Accruals (99 of 100).

Will CDLX stock go up?

No one can know that. What the data says: the median 12-month target from 4 analysts implies +16.3% from the last close, and Ticker Nerd's factor model ranks Cardlytics, Inc. 83 out of 100 as at 22 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the CDLX stock forecast for 2030?

No analyst covering Cardlytics, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CDLX are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $4 to $10 over the next 12 months.

How has CDLX stock performed over the past year?

Cardlytics, Inc. returned -57.4% over the 12 months to 21 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Cardlytics, Inc. do?

Cardlytics, Inc. is a commerce media platform powered by publishers' first-party purchase data, operating primarily in the United States and the United Kingdom.

What is the latest news on CDLX?

The most recent item we track (Seeking Alpha, 6 Aug 2026): "Cardlytics, Inc. (CDLX) Q2 2026 Earnings Call Transcript". Seeking Alpha published the transcript of Cardlytics, Inc.'s Q2 2026 earnings call, in which company management presented the quarter's results and answered analyst questions.

Company

About Cardlytics, Inc.

Cardlytics, Inc. is a commerce media platform powered by publishers' first-party purchase data, operating primarily in the United States and the United Kingdom. It provides solutions that enable advertisers to reach consumers through digital channels including online platforms, mobile applications, email, and real-time notifications, driving targeted marketing and incremental sales via its card-linked offer network. The company manages two key platforms: the Cardlytics Platform, which offers proprietary advertising channels leveraging visibility into a significant portion of card-based transactions, and the Bridg Platform, a customer data platform that uses point-of-sale data from merchant partners for privacy-protected analytics and targeted loyalty marketing. Cardlytics, Inc. supports marketers and publishers in strengthening customer relationships and enhancing commerce outcomes across various sectors. Founded in 2008 and headquartered in Atlanta, Georgia, it plays a vital role in the digital advertising and media industry by integrating purchase insights to optimize marketing effectiveness.

CEO Mr. Amit Gupta · 275 employees · United States · https://www.cardlytics.com